Stay informed. See MDA updates on COVID-19

Medical Educational Resource

We're accelerating the delivery of treatments and cures.

Recent Developments in the Spinal Muscular Atrophy Treatment Landscape

Activity Snapshot

Activity Type: 
On-Demand Webinar
Release Date: 
Friday, October 25, 2019
Expiration Date: 
Tuesday, October 25, 2022
Sponsor Information: 

This program is supported in part by an independent medical education grant from AveXis Inc.

Faculty

Julie A. Parsons, MD
Julie A. Parsons, MD
Professor of Clinical Pediatrics and Neurology. Haberfeld Family Endowed Chair in Pediatric Neuromuscular Disorders Co-Director, Neuromuscular Clinic . University of Colorado School of Medicine and Children’s Hospital Colorado
Claudia A. Chiriboga, MD, MPH
Claudia A. Chiriboga, MD, MPH
Professor of Neurology and Pediatrics - Columbia University Irving Medical Center and New York–Presbyterian Hospital
Recent Development SMA
Activity Overview: 

This webinar will help physicians learn about rapidly changing treatment options in SMA and facilitate the integration of new treatments into the comprehensive management of patients with SMA. MDA invites clinicians in our community to use this resource to educate themselves and other providers, while earning CME credits.

Learning Objectives: 
  • Explain the importance of a timely, accurate SMA diagnosis and why early intervention is crucial​
  • Compare and contrast the different therapies on the market or in clinical development, their administration, and the appropriate patient populations for each ​
  • Identify and recognize additional disease phenotypes that may manifest over the course of the disease
Accreditation and Designation Statement: 

This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of PeerPoint Medical Education Institute, LLC and Muscular Dystrophy Association. The PeerPoint Medical Education Institute, LLC is accredited by the ACCME to provide continuing medical education for physicians.

The PeerPoint Medical Education Institute, LLC designates this Enduring Material activity for a maximum of .75 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

How to Obtain CME credits : 

Once you have viewed the program, MDA will share back with you instructions for how to obtain your CME credits. If you have questions on this process, please reach out to cmemanagement@mdausa.org.

Faculty Disclosures: 

The following presenters, planners, editors, or staff have relevant financial relationships to disclose:

"I, or an immediate family member, have at present or have had within the last 12 months, the following affiliation with one or more organizations that could be perceived as a real or apparent conflict of interest in context to the design, implementation, presentation, evaluation, etc. of CME Activities."

Dr. Julie Parsons:
Biogen: Advisory Board, Principal Investigator; consulting fee, research support
AveXis: Advisory Board, Principal Investigator; consulting fee, research support
Scholar Rock: Principal Investigator; research support

Dr. Claudia Chiriboga:
AveXis: Consultant; consulting fee
Roche/Genentec: Consultant; consulting fee
Biogen: Educational speaker; honoraria

All other presenters, planners, editors, or staff reported no relevant relationships with the following statement:

"I, or an immediate family member, do not have at present, or within the last 12 months, nor anticipate having financial interest, arrangement or affiliation with any organizations that could be perceived as a real or apparent conflict of interest in context to the design, implementation, presentation, evaluation, etc. of CME Activities."

Copyright 2021 Muscular Dystrophy Association. All rights reserved. The Medical Education Program(s) in their entirety (including, but not limited to: webinar(s), speaker deck presentation(s), MDA Monthly Report content and case studies) are owned by Muscular Dystrophy Association and the associated partner(s) and may not be copied, reproduced, or altered in any manner without MDA’s prior written consent except that the User(s) may download, view, or use these program(s) for educational purposes only.

The Terms of Use permit User(s) to use the Medical Education Program(s) for personal and/or public education only. A User may download the information to share but will not be permitted to alter the information in any way. The User(s) is permitted to educate on one or all sections of the program(s). Any appropriate use of content available from the Medical Education Program(s) must not remove any trademarks, copyright, or any other notice contained in such content.

If you wish to alter any of the Medical Education Program(s) presented by the MDA in a form other than what is set out on mda.org, please consult meded@mdausa.org.